• SENSEX 77,728.40
    72.31 (+0.09%)
  • BANKNIFTY 57,514.20
    -11.75 (--0.02%)
  • Rubicon Research
    1,803.65 1,827.50(%)
  • Viyash Scientific
    263.20 167.50(%)
  • Billionbrains
    195.20 112.02(%)
  • Hindustan Copper
    551.80 759.20(%)
  • Netweb Technol.
    5,467.80 5,810.00(%)
  • Welspun Corp
    2,204.70 709.75(%)
  • Federal-Mogul Go
    578.00 578.50(%)
  • Cyient
    1,054.60 1,282.40(%)
  • Hindustan Zinc
    623.95 732.60(%)
  • Ather Energy
    1,487.00 1,589.40(%)
  • Health.Global
    717.25 513.40(%)
  • Polycab India
    9,158.00 10,128.60(%)
  • Multi Comm. Exc.
    3,320.95 3,479.80(%)
  • ICICI Bank
    1,446.00 1,479.90(%)
  • Phoenix Mills
    1,927.45 1,465.30(%)
  • Varun Beverages
    425.55 381.00(%)
  • Cholaman.Inv.&Fn
    1,925.25 1,952.00(%)
  • Dhoot Transmission
    1,566.05 1,541.00(%)
  • HDFC Bank
    724.55 715.05(%)
  • Genesys Intl.
    252.45 441.83(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Wockhardt Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Wockhardt
  • BSE Code : 8021.0
  • ISIN : INE049B01025
1,899.60 -1 (-0.07%)
  • As on 26 Aug 2026 (EOD)

  • Today’s Low

    1,869.60

  • Today’s High

    1,914.20

  • Open

    1,895.10

  • Perv Close

    1,901.00

  • 52W Low

    1,086.70

  • 52W High

    2,422.30

Key Indicators

  • P/E(TTM)

    93.12

  • Mar.Cap (₹Cr.)

    30,867.01

  • Div & Yield %

    0.00

  • Book Value(₹)

    189.81

  • Debt-Equity Ratio

    -0.07

  • AGM Date

    25-Aug-2026

  • EPS

    20.37

  • P/E Ratio

    93.12

Financials Ratios

  • Debt-Equity Ratio

    0.68

  • Mar.Cap (₹Cr.)

    30,867.01

  • RONW (%)

    -12.34

  • ROCE (%)

    -0.86

Score Board

  • Equity (₹ in Cr.)

    81.25

  • BV (₹)

    189.80

  • Sales( ₹ in Cr.)

    1,739.00

  • NP (in Cr.)

    292.00

  • NP Var(%)

    2533.0

  • Div%

    0.0

  • CPS (₹)

    29.40

  • EPS (₹)

    18.00

  • Traded Value (₹ in Lakhs)

    30,822.33

  • 52 Week High

    2,422.30

  • 52 Week Low

    1,086.70

  • Price BSE

    1897.0

  • Price NSE

    1,900.00

  • Market Capital( in Cr.)

    30,822.33

  • P/C Ratio

    64.50

  • P/E Ratio

    105.60

  • Price Vs.BV

    18.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,739.00 1,402.00 1,154.00 1,072.00 1,372.00 987.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,739.00 1,402.00 1,154.00 1,072.00 1,372.00 987.00
Other Income 162.00 55.00 41.00 67.00 38.00 1,026.00
Stock Adjustments 92.00 46.00 -14.00 -30.00 -2.00 2.00
Total Income 1,993.00 1,503.00 1,181.00 1,109.00 1,408.00 2,015.00
EXPENDITURE :            
Raw Materials 507.00 482.00 447.00 371.00 474.00 418.00
Power and Fuel Cost 73.00 75.00 68.00 54.00 62.00 55.00
Employee Cost 313.00 262.00 247.00 240.00 261.00 293.00
Other Manufacturing Expenses 123.00 96.00 71.00 60.00 94.00 86.00
Selling and Administration Expenses 217.00 179.00 179.00 178.00 181.00 166.00
Miscellaneous Expenses 81.00 54.00 178.00 304.00 76.00 251.00
Employee Benefit Expenses 313.00 262.00 247.00 240.00 261.00 293.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,314.00 1,148.00 1,190.00 1,207.00 1,148.00 1,269.00
Operating Profit 679.00 355.00 -9.00 -98.00 260.00 746.00
Interest 176.00 199.00 237.00 229.00 273.00 200.00
Gross Profit 503.00 156.00 -246.00 -327.00 -13.00 546.00
Depreciation 186.00 168.00 176.00 186.00 171.00 184.00
Profit Before Tax 317.00 -12.00 -422.00 -513.00 -184.00 362.00
Current Tax 0.00 0.00 0.00 0.00 5.00 -136.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 -47.00 -49.00 -95.00
Reported Net Profit 317.00 -12.00 -422.00 -466.00 -140.00 593.00
Extraordinary Items 25.00 0.00 -14.00 -235.00 0.00 -142.00
Adjusted Net Profit 292.00 -12.00 -408.00 -231.00 -140.00 735.00
Adjustment below Net Profit 0.00 0.00 0.00 4.00 -1.00 0.00
P & L Balance brought forward -902.00 -890.00 -468.00 -3.00 138.00 -125.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 330.00
P & L Balance carried down -585.00 -902.00 -890.00 -465.00 -3.00 138.00
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 19.57 -0.74 -27.40 -32.36 -9.72 53.91
Earnings Per Share(Adj)-Unit Curr 19.57 -0.74 -27.40 -32.36 -9.72 49.68
Book Value 190.37 170.56 116.62 121.74 153.61 146.00
Book Value(Adj)-Unit Curr 190.37 170.56 116.62 121.74 153.61 134.54

Shareholding Pattern

  • Promoter Group

    49.08%

  • Public Share Holding

    50.92%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,180,051 0.73 1,180,051 6
Partnership Firms-Indian (Promoter & Group) 76,587,516 47.13 76,587,516 4
Persons Acting in Concert 0 0.00 0 0
Trusts 1,991,281 1.23 1,991,281 4
Others 0 0.00 0 0
Sub Total 79,758,848 49.08 79,758,848 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 27,784 0.02 27,784 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 630 0.00 130 4
Foreign Bank 10,200 0.01 10,200 2
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,726,551 7.22 11,725,351 126
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 337,417 0.21 336,017 6
Mutual Funds / UTI 11,036,678 6.79 11,036,678 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,633,043 2.24 3,633,043 34
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 26,772,303 16.48 26,769,203 198
2] Non Institution
Bodies Corporate 4,564,669 2.81 4,562,869 1,150
Clearing Members 1,102,455 0.68 1,102,455 91
Directors of their Relatives 295 0.00 295 2
Employees 117,531 0.07 117,531 270
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,059,481 1.27 2,054,381 4,279
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,824,764 1.12 1,824,764 4,016
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,733,003 7.84 12,733,003 83
Individuals holding nominal share capital up to Rs. 1 lakh 31,636,163 19.47 31,297,768 156,209
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,555 0.00 1,555 7
Others 318,418 0.20 318,418 2
Sub Total 55,961,018 34.44 55,615,723 166,306
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 162,492,169 100.00 162,143,774 166,518

Company Background

Wockhardt LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Wockhardt Ltd
  • BSE Code : 8021.0
  • ISIN : INE049B01025

  • Incorporation Year

    1999

  • Registered Office

    D-4 MIDC
    Chikalthana, AURANGABAD,
    Maharashtra-431006

  • Telephone

    91-240-6694444

  • FAX

    91-240-2489219

  • Chairman

    H F Khorakiwala

  • Managing Director

  • Company Secretary

    Rashmi Mamtura

  • Auditor

    MSKC & Associates LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Wockhardt Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Wockhardt 1,896.85 1,876.00 1,739.00 86.57 9.61
Abbott India 26,435.25 7,217.19 6,929.05 34.79 43.78
Astrazeneca Phar 7,166.30 2,304.07 2,275.58 105.62 27.86
Glaxosmi. Pharma 2,980.05 3,932.76 3,790.20 47.60 58.17
Novartis India 1,499.85 398.23 356.27 37.88 16.64
Cipla 1,420.00 20,102.60 18,979.95 37.32 13.88
Bliss GVS Pharma 560.20 773.53 729.81 52.01 12.51
Amrutanjan Healt 522.20 469.50 451.82 27.97 21.89
Fermenta Biotec. 468.60 474.15 450.25 21.88 18.77
Guj. Themis Bio. 407.20 152.47 150.80 91.10 27.21
Ambalal Sarabhai 44.30 19.52 3.94 82.04 6.77